Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DOD Biotech PCL's operating cash flow per share for the
three
months ended in Jun. 2026 was ฿0.04.
DOD Biotech PCL's operating cash flow per share for the trailing twelve months (TTM) ended in Jun. 2026 was ฿-0.05.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of DOD Biotech PCL was -133.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for DOD Biotech PCL's Operating Cash Flow per Share or its related term are showing as below:
During the past 12 years, DOD Biotech PCL's highest 3-Year average Operating Cash Flow per Share Growth Rate was 27.20% per year. The lowest was -59.50% per year. And the median was -39.80% per year.
BKK:DOD-R's 3-Year OCF Growth Rate is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 10.5 * Ranked among companies with meaningful 3-Year OCF Growth Rate only.
DOD Biotech PCL Operating Cash Flow per Share Related Terms
DOD Biotech PCL Operating Cash Flow per Share Historical Data
* Premium members only.
The historical data trend for DOD Biotech PCL's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DOD Biotech PCL Operating Cash Flow per Share Chart
BKK:DOD-R vs KHC, GIS: Operating Cash Flow per Share Comparison
For the Packaged Foods subindustry, DOD Biotech PCL's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DOD Biotech PCL Price-to-Operating-Cash-Flow vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, DOD Biotech PCL's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where DOD Biotech PCL's Price-to-Operating-Cash-Flow falls into.
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿-0.05
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Operating Cash Flow per Share of ฿-0.05 mean?
DOD Biotech PCL (BKK:DOD-R) has a Operating Cash Flow per Share of ฿-0.05 as of Jun. 2026. Operating cash flow per share equals the per-share amount of cash flow from operations. View historical data on DOD Biotech PCL and its competitors. According to the industry distribution chart, DOD Biotech PCL ranks #999999 out of 1442 companies in the Consumer Packaged Goods industry.
Is DOD Biotech PCL's Operating Cash Flow per Share too high?
DOD Biotech PCL's current Operating Cash Flow per Share is ฿-0.05. Based on the distribution chart, DOD Biotech PCL ranks #999999 out of 1442 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, DOD Biotech PCL has a GF Score™ of 67/100, reflecting its overall financial health beyond just this single metric.
How does DOD Biotech PCL's Operating Cash Flow per Share compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, DOD Biotech PCL ranks #999999 out of 1442 companies for Operating Cash Flow per Share. This places DOD Biotech PCL in the lower half of its industry. The industry median Operating Cash Flow per Share is 10.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Cash Flow per Share for a Consumer Packaged Goods company?
The median Operating Cash Flow per Share among Consumer Packaged Goods companies is 10.50, based on 1,442 companies in the industry. Companies in the top quartile (top 25%) have a Operating Cash Flow per Share significantly above this median, while those in the bottom quartile fall well below. However, Operating Cash Flow per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Cash Flow per Share mean?
A high Operating Cash Flow per Share can signal that a stock is expensive relative to its fundamentals. Operating cash flow per share equals the per-share amount of cash flow from operations. View historical data on DOD Biotech PCL and its competitors. For the Consumer Packaged Goods industry, the median Operating Cash Flow per Share is 10.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DOD Biotech PCL's current Operating Cash Flow per Share is ฿-0.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DOD Biotech PCL stock overvalued right now?
DOD Biotech PCL (BKK:DOD-R) has a current Operating Cash Flow per Share of ฿-0.05. The stock's GF Value™ is ฿1.52, compared to a current price of ฿0.97 — trading 36.4% below its estimated fair value. The current Operating Cash Flow per Share is ฿-0.05. DOD Biotech PCL's overall GF Score™ is 67/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Cash Flow per Share calculated?
Operating Cash Flow per Share is calculated from a company's financial statements. For DOD Biotech PCL (BKK:DOD-R), the current Operating Cash Flow per Share is ฿-0.05 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DOD Biotech PCL (BKK:DOD-R) Overvalued in 2026?
Based on GuruFocus' analysis, DOD Biotech PCL stock appears to be undervalued.
The current stock price of ฿0.97 is trading 36.4% below its estimated GF Value™ of ฿1.52.
Key valuation signals for BKK:DOD-R:
Operating Cash Flow per Share: ฿-0.05
GF Value™: ฿1.52 vs. price of ฿0.97 (36.4% below fair value)
No single metric tells the full story. See the BKK:DOD-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DOD Biotech PCL is principally engaged in the manufacture and distribution of food supplements and health drinks of all kinds. The group is principally engaged in the supplement business. Its operations are carried on only in Thailand. Its products include: Capsule; Gel; Jelly; Powder for making drinks; Concentrated water extract (Shot Drink); Softgel; Tablet; Probiotics; Gummies; and Direct-to-Mouth Packaging.
67GF Score
Get the complete analysis for BKK:DOD-R
Operating Cash Flow per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:DOD-R has been successfully added to your 
